BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastroenterol. Nov 21, 2025; 31(43): 111976
Published online Nov 21, 2025. doi: 10.3748/wjg.v31.i43.111976
Table 1 Baseline characteristics of included patients stratified by disease, mean ± SD/n (%)
Characteristics
Total (n = 83)
ACLF (n = 44)
AD (n = 16)
Cirrhosis (n = 23)
P value
Age in years48.8 ± 9.447.0 ± 8.450.9 ± 9.350.7 ± 10.90.057
Male67 (80.7)41 (93.2)12 (75.0)14 (60.9)0.003
Etiology10.038
HBV55 (66.3)35 (79.6)9 (56.2)11 (47.8)
HCV1 (1.2)1 (2.3)00
Alcohol8 (9.6)2 (4.5)3 (18.8)3 (13.0)
Autoimmune11 (13.3)3 (6.8)3 (18.8)5 (21.8)
Mixed5 (6.0)3 (6.8)1 (6.2)1 (4.4)
Other3 (3.6)003 (13.0)
Laboratory data
Albumin in g/L33.8 ± 5.434.4 ± 4.931.5 ± 5.934.5 ± 5.90.156
ALT in U/L, median IQR42.0 (26.0-86.0)56.5 (37.3-98.3)37.5 (27.0-87.3)26.0 (16.0-38.0)< 0.001
AST in U/L, median IQR70.0 (45.0-115.0)99.5 (53.8-120.8)86.0 (49.5-183.5)41.0 (30.0-52.0)< 0.001
TB in μmol/L301.9 ± 240.7461.1 ± 180.4241.9 ± 195.939.0 ± 26.0< 0.001
Creatinine in mg/dL, median IQR0.7 (0.6-1.1)0.8 (0.6-1.4)0.7 (0.6-0.9)0.7 (0.5-1.3)0.424
Serum urea in mmol/L, median IQR5.6 (3.8-7.9)5.7 (3.8-9.1)5.5 (4.1-7.5)5.5 (3.6-7.1)0.833
INR, median IQR1.9 (1.4-2.6)2.5 (2.0-3.0)1.6 (1.4-2.0)1.3 (1.2-1.6)< 0.001
WBC as 109/L, median IQR5.0 (3.5-7.9)6.7 (4.3-8.5)4.4 (2.2-6.6)3.6 (2.6-4.2)< 0.001
Neutrophil as 109/L, median IQR3.4 (2.2-5.5)4.7 (3.0-6.9)2.9 (1.5-4.7)2.1 (1.6-2.8)< 0.001
Perioperative complications
Infection43 (51.8)24 (54.5)7 (43.8)12 (52.2)0.800
PNF4 (4.8)3 (6.8)0 (0)1 (4.3)0.811
EAD31 (37.3)20 (45.5)2 (12.5)9 (39.1)0.061


Write to the Help Desk